Simvastatin Attenuates Abdominal Aortic Aneurysm Formation Favoured by Lack of Nrf2 Transcriptional Activity

Abstract EN

Surgical intervention is currently the only option for an abdominal aortic aneurysm (AAA), preventing its rupture and sudden death of a patient.

Therefore, it is crucial to determine the pathogenic mechanisms of this disease for the development of effective pharmacological therapies.

Oxidative stress is said to be one of the pivotal factors in the pathogenesis of AAAs.

Thus, we aimed to evaluate the significance of nuclear factor erythroid 2-related factor 2 (Nrf2) transcriptional activity in the development of AAA and to verify if simvastatin, administered as pre- and cotreatment, may counteract this structural malformation.

Experiments were performed on mice with inhibited transcriptional activity of Nrf2 (tKO) and wild-type (WT) counterparts.

We used a model of angiotensin II- (AngII-) induced AAA, combined with a fat-enriched diet.

Mice were administered with AngII or saline for up to 28 days via osmotic minipumps.

Simvastatin administration was started 7 days before the osmotic pump placement and then continued until the end of the experiment.

We found that Nrf2 inactivation increased the risk of development and rupture of AAA.

Importantly, these effects were reversed by simvastatin in tKO mice, but not in WT.

The abrupt blood pressure rise induced by AngII was mitigated in simvastatin-treated animals regardless of the genotype.

Simvastatin-affected parameters that differed between the healthy structure of the aorta and aneurysmal tissue included immune cell infiltration of the aortic wall, VCAM1 mRNA and protein level, extracellular matrix degradation, TGF-β1 mRNA level, and ERK phosphorylation, but neither oxidative stress nor the level of Angiotensin II Type 1 Receptor (AT1R).

Taken together, the inhibition of Nrf2 transcriptional activity facilitates AAA formation in mice, which can be prevented by simvastatin.

It suggests that statin treatment of patients with hypercholesterolemia might have not only a beneficial effect in terms of controlling atherosclerosis but also potential AAA prevention.